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ABSTRACT

Yan, Zhongyu. Ph.D., Biomedical Sciences Ph.D. Program, Wright State University,
2010
Characterization of Chlorpyrifos Toxicity on the Pancreatic Beta cell line RINm5f

Chlorpyrifos (CPF) is a well-known organophosphate (OP) insecticide that inhibits
acetylcholinesterase (AChE). Organophosphates have been shown to induce
hyperglycemia in both humans and animals that cannot be explained by AChE
inhibition alone. Pancreatic β-cells are responsible for secreting insulin and playing a
fundamental role in glucose homeostasis. The aim of this research was to investigate
CPF toxicity on the insulin secreting β-cell line RINm5f (RIN). In the first part of this
dissertation, we determined that cytotoxic concentrations of CPF between 50 µM and
200 µM induced a dose-dependent increase in RIN cell apoptotic and necrotic death
(p<0.05). Lower doses, i.e., 5-25 µM did not induce apoptosis or necrosis. In further
mechanistic studies, inhibitors of c-Jun N-terminal kinase (JNK) and P38 pathways, i.e.,
SP600125 and SB202190, successfully attenuated CPF-induced apoptosis (p<0.05),
suggesting cell death is mediated by JNK and/or p38. In addition, N-Acetyl-L-cysteine
(NAC), an antioxidant, inhibited apoptosis suggesting that oxidative stress is also
involved in RIN cell death. In the second part of this dissertation, low dose CPF’s effects
on insulin synthesis and secretion was studied. Our results showed that RIN cells
treated with CPF for 4 hr exhibited a dose-dependent decrease in insulin secretion in
response to stimulation by 50 mM potassium (p<0.05). Insulin secretion stimulated by
iii

25 mM glucose also showed significant decreases upon incubation with various doses
of CPF (p<0.05). Insulin synthesis involves proteolytic cleavage of proinsulin at two
specific sites. The enzymes responsible for promoting proinsulin cleavage, i.e,
prohormone convertase (PC) 1/3 and 2 (PC2), contain a serine hydrolase catalytic triad,
His-Asp-Ser, similar to AChE. CPF modification of PC enzymes similar to AChE,
could potentially interrupt the conversion of proinsulin to insulin and disrupt insulin
secretion. PC2 enzyme activity was significantly inhibited by CPF at concentrations as
low as 10 µM (p<0.01). RIN cells, for the first time, were found to secrete proinsulin
was through a constitutive instead of a regulated pathway. In summary, our results
show that CPF not only exerts a direct cytotoxic effect at concentrations above 50 µM,
but also significantly impairs insulin secretion at lower doses. Low dose CPF could
potentially affect endocrine function in vivo by inhibiting the proinsulin processing
enzyme PC2.
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Background and Significance

Chemical and Physical Properties of Chlorpyrifos

FIG. 1. Chemical Structure of CPF
Chlorpyrifos (O, O-diethyl O-3, 5, 6- trichlopyridin-2-pyridyl phosphorothioate)
(CPF) is one of the organophosphorous (OP) pesticides (Figure 1).

It is well known

that toxicity of OP pesticides is via persistent inhibition of an enzyme,
acetylcholinesterase (AChE), in the brain and peripheral nervous system (Rosenfeld et
al. 2006; Shenouda et al. 2009). AChE is primarily located in the postsynaptic
membrane of central and peripheral cholinergic systems. The inhibition of AChE
results in decreased degradation of a neurotransmitter, acetylcholine, leading to
overstimulation of the associated synaptic systems (Figure 2). Symptoms of exposure
include nausea, headaches, twitching, trembling, excessive salivation and tearing,
inability to breathe because of paralysis of the diaphragm, convulsions, and at higher
doses, death (Simpson et al. 2002).

1

FIG. 2. Schematic drawing of OP on the inhibition of acetylcholine signaling.

2

Uses of CPF
About 70% of insecticides used in the United States are OPs. Since first introduced
into the marketplace in 1965, CPF has been widely used worldwide as an insecticide to
control pests in agriculture, home, lawns and golf courses and to control mosquitoes
(EPA 2009). Residential use of CPF was eliminated in the United States in 2001(EPA
2001). However, CPF continues to be used to control crop damage from insects in
agriculture. In 2002-2006, the United States accounted for 16% of total worldwide
agriculture use of CPF and 26% with regard to nonagricultural use from just one
company, i.e., Dow AgroSciences (Eaton et al. 2008). In California, 2.3 million pounds
of CPF were reported sold in 2004 (California Department of Pesticide Regulation
2004)
Biotransformation of CPF
CPF undergoes biotransformation by different pathways and tissues in the
body (Figure 3). Cytochrome P-450 (CYP) is responsible for oxidative desulfuration
of CPF to form chlorpyrifos-oxon (CPO). CPO is responsible for inhibition of AChE.
The rate of desulfuration in the liver microsomes is 1000 times the rate in brain
microsomal and crude mitochondrial fractions, i.e. 3-27 pmol/g/min vs. 4-28
nmol/g/min respectively (Chambers et al. 1989). CPO can be detoxified by oxonases,
such

as

paraoxonase

(PON)

to

form

diethylphosphate

(DEP)

and

3,5,6-trichloro-2-pyridinol (TCPy). CYP enzymes also catalyze dearylation of CPF to
diethyl thiophosphate (DETP) and TCPy (Jokanovic 2001). Different isoforms of CYP
enzymes have different capacities to convert CPF to its oxon form and to detoxify CPF.
3

FIG. 3. Biotransformation of CPF
CPF is activated to CPF--oxon (CPO) by CYP (to the left) and then is detoxified by
paraoxonase (PON).. CYP enzymes catalyze dearylation of CPF to the inactive
metabolites i.e., DEPT, DEP and TCPy.
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TCPy and glucoronide and sulfate conjugates of TCPy are inactive metabolites of
CPF and are excreted in the urine and feces.
Exposure to CPF
Exposure to CPF can be through direct dermal contact, contact with treated
surfaces, ingestion of CPF contaminated dust, and by breathing air inside or outside
treated buildings (Pesticide Action Network North America 2006). Exposure also
results from eating food contaminated with CPF residues (Fenske et al. 2002). Data
from the Center for Disease Control and Prevention (CDC) showed that 93% of U.S.
residents sampled between 1999 and 2000 had CPF in their bodies. CPF is found in
higher levels (nearly 2 x) in children compared with adults (Schafer et al. 2004). The
reasons for this are believed to be that children have different activity patterns. For
example children are closer to the ground and put more toys in their mouths (Bearer
1995; Landrigan et al. 1999; O'Rourke et al. 2000). They also consume more food and
water per body weight than adults (Bearer 1995; Landrigan et al. 1999). In addition,
children have a greater surface to volume ratio which can increase the absorption of
CPF or its metabolites from their skin (Bearer 1995; Landrigan et al. 1999; Needham et
al. 2000).
CPF Toxicity
A wide variety of effects have been seen with CPF and CPO in in vitro studies.
These effects fall into 8 categories: cytotoxicity, effects on macromolecule synthesis
(DNA, RNA, proteins), interactions with neurotransmitter receptors, interactions with
signal transduction pathways, effects on neuronal differentiation, interactions with
5

enzymes, neurotransmitter release or uptake, and oxidative stress (Eaton et al. 2008).
Micromolar concentrations of CPF were found to cause cytotoxicity in many in
vitro studies (Table 1). In the human monocyte cell line, U937, CPF induced apoptosis
in a time- and dose-dependent manner (Nakadai et al. 2006). Human placental
choriocarcinoma (JAR) cells exhibited a dose-dependent reduction in viability starting
at a concentration of 31.25 µM (Saulsbury et al. 2008). Primary cortical neurons
cultured from embryonic and newborn rats also showed apoptosis following exposure
to CPF (Caughlan et al. 2004). However, no studies have been done to evaluate CPF
cytotoxicity on pancreatic cells in vitro.
CPF and CPO were observed to inhibit macromolecule synthesis, in particular,
DNA synthesis at micromolar concentrations (Garcia et al. 2001; Qiao et al. 2001;
Guizzetti et al. 2005; Jameson et al. 2006). Garcia et al found that CPF and CPO
induced a concentration-dependent inhibition in [3H] thymidine incorporation in
astroglial cells (Guizzetti et al. 2005). Meanwhile, inhibition of DNA synthesis in an
adrenal gland cell line, PC12, and glial cell line, C6, was also reported (Qiao et al.
2001). Although further studies are needed to investigate potential cellular and
molecular mechanisms involved in the DNA inhibition, there is evidence that
transcriptional events that mediate cell division and differentiation are interrupted. This
includes decreased DNA binding activity of transcription factor AP-1 in the presence of
CPF and CPO (Crumpton et al. 2000; Garcia et al. 2001). In regard to signal
transduction pathways, CPF and CPO were found to inhibit adenylate cyclase, possibly
through activation of muscarinic M2 receptors (Song et al. 1997; Aldridge, Justin E. et
6

al. 2003; Meyer et al. 2004; Meyer et al. 2005).
Evidence for interaction of CPF and CPO with cholinergic muscarinic receptors
has been found (Liu et al. 1999; Tang et al. 1999; Qiao, D. et al. 2002; Richardson et al.
2004). Decreased density of muscarinic M2 receptors has also been observed (Liu et al.
1999; Tang et al. 1999; Qiao, D et al. 2002; Rhodes et al. 2004; Richardson et al. 2004).
In binding studies, CPF and CPO have been shown to displace agonists from
muscarinic receptors (Huff et al. 1994). This suggests CPF and/ or CPO may interact
directly with the receptors and downregulate them.
Many papers have demonstrated that CPF induces oxidative stress (Bagchi et al.
1995; Crumpton et al. 2000; Giordano et al. 2007; Buyukokuroglu et al. 2008).
Oxidative stress refers to an imbalance between the elevated levels of reactive oxygen
species (ROS) and/or compromised function of the antioxidant defense system (Sies
1997). ROS includes superoxide anion (O2 .-), hydroxyl radicals (.OH), and hydrogen
peroxide (H2O2). CPF has the ability to promote glutathione depletion, active oxygen
formation, and lipid peroxidation in various in vitro preparations and in vivo studies.
Meanwhile, the addition of an antioxidant, prevented the production of lipid
peroxidation in the presence of CPO (Qiao et al. 2005). Melatonin, an antioxidant that
protects lipids, proteins and DNA from oxidative damage, suppressed CPF-caused
HepG2 (a human hepatocellular carcinoma cell line) cytotoxicity (Gultekin et al.
2006).
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Table 1
Summary of In vitro cell viability affected by CPF
Cell line/ tissue

Effects

CPF concentration

Reference

U937 cells

Apoptosis

20 µM

(Nakadai et al. 2006)

Rat cortical neurons

Apoptosis

30 µM

(Caughlan et al. 2004)

Human astrocytes

Apoptosis

100 µM

(Mense et al. 2006)

Human placental

Apoptosis

60 µM

(Saulsbury et al. 2008)

Human astrocytes

Necrosis

0.2 µM

(Mense et al. 2006)

U937 cells

LDH release

70 µM

(Nakadai et al. 2006)

Rat cortical neurons

MTT reduction

15 µM

(Caughlan et al. 2004)

Mouse CGNs

MTT reduction

12 µM

(Giordano et al. 2007)

MTT reduction

31.25 µM

(Saulsbury et al. 2008)

1321N1 cells

Trypan blue

50 µM

(Guizzetti et al. 2005)

(human astrocytoma cell line)

exclusion
500 µM

(Cool et al.

(human mococyte cell line)

choriocarcinoma

(human mococyte cell line)

(cerebellar granule neurons)
Human placental
choriocarcinoma

HepG2 cells

Decreased

(human hepatoma cell line)

proliferation

Pituitary rat GH3 cells

Decreased

upublished)
50 µM

(Ghisari et al. 2005)

1 µM

(Cool et al.

proliferation
HepG2 cells

Increased

(human hepatoma cell line)

proliferation

Pituitary rat GH3 cells

Increased

unpublished)
10 µM

proliferation

8

(Ghisari et al. 2005)

In vivo toxicity of CPF includes neurotoxicity, carcinogenesis and reproductive
toxicity. Many studies demonstrate that exposure to CPF interferes with development
of mammalian nervous system (Aldridge et al. 2003; Aldridge et al. 2005; Slotkin et al.
2005; Slotkin et al. 2006). It is believed that oxidative stress is one of the mechanisms
involved in OP-induced neurotoxicity (Slotkin et al. 2005), however, there are other
mechanisms. For example, nontoxic exposure to CPF on gestational days (GD) 17-20
or postnatal days (PN) 1-4 in rats evoked increases in serotonin (5HT) turnover which
is associated with behavioral anomalies (Aldridge et al. 2005). A new analysis links
children's attention-deficit disorder with exposure to common pesticides including CPF.
The study included 1139 children from 8 to 15 years of age with average exposure to
OP pesticides. Children with higher levels of pesticide residue in their bodies had
increased chances of having ADHD, attention-deficit hyperactivity disorder, a common
problem that causes students to have trouble in school (Bouchard et al. 2010).
Although no evidence of CPF carcinogenicity has been found by the U.S EPA,
several human epidemiology studies have suggested possible links between CPF and
lung and rectal cancers (Lee et al. 2004; Lee et al. 2007).
Reproductive toxicity also has received much attention. Farag et al. reported that
male mice treated with 25 mg/kg CPF for 4 weeks before mating with untreated
females was associated with decreased number of live fetuses, and increased number of
dead fetuses (Farag et al. 2010). Exposure to CPF in utero has been shown to result in
low birth weights and reduced head circumference of newborns especially for
individuals who have low levels of PON1 (Whyatt et al. 2001; Berkowitz et al. 2004;
9

Whyatt et al. 2004; Furlong et al. 2006).
To date, the majority of CPF research has focused on the formation and metabolism
of CPO, as this metabolite causes the irreversible inhibition of AChE activity through
binding to serine at the enzyme active site. It should be recognized that there are many
other serine hydrolases that are potential secondary targets for the oxon (Figure 4).
These enzymes are fatty acid amide hydrolase (FAAH), diacylglycerol (DAG) lipase,
acylpeptide

hydrolase

(APH),

NTE-lysophopholipase

(NTE-lysoPLA),

monoacylglycerol (MAG) lipase, and serine hydorlase KIAA1363 (Casida et al. 2004;
Casida et al. 2005; Nomura et al. 2006; Nomura et al. 2008). Several serine hydrolases
were found to be inhibited by CPO at medium to high nanomolar concentrations, for
example, serine hydrolase KIAA1363 at 8 nM, FAAH at 40 nM, APH at 82 nM and
NTE-lysoPLA at 180 nM. However, knowledge of the role of the majority of serine
hydrolases and the consequences of their inhibition is still very limited.
CPF and hyperglycemia
Hyperglycemia is one of the effects of OPs in acute and subchronic exposures
(Gupta 1974; Zadik et al. 1983; Shobha et al. 2000; Abdollahi et al. 2004; Pourkhalili
et al. 2009). In humans, OP-related poisonings raised blood glucose up to five fold
(Namba et al. 1971; Hayes et al. 1978; Meller et al. 1981; Matin et al. 1982).
OP-caused hyperglycemia has been confirmed in laboratory animals as well (Dybing et
al. 1958; Matin et al. 1982; Fletcher et al. 1988; Abdollahi et al. 2004; Pourkhalili et al.
2009). Although hyperglycemia by OPs is well demonstrated, the underlying
mechanism is unknown. Previous research has mainly linked hyperglycemia to OP
10

FIG. 4. Known primary and secondary targets of organophosphates.
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induced liver deregulation. Goel et al. indicated that CPF treatment induces a variety of
alterations in carbohydrate metabolizing enzymes in rat tissues (Goel et al. 2006).
Specifically, they found a significant elevation of glycogen phosphorylase, decreased
glycogen levels, significantly inhibited hexokinase activity which suppressed
glycolysis,

increased

activity

of

glucose-6-phosphatase

(increased

rate

of

glycogenolysis) and decreased 14C-glucose uptake. Rezg et al. showed that subchronic
exposure to malathion (one of the OPs) significantly decreased hepatic protein and lipid
contents which might be associated with increased liver gluconeogenesis (Rezg et al.
2007).
CPF and Pancreas Toxicity
In our laboratory, we are interested in the toxicity associated with the endocrine
system, especially the pancreas. The pancreas is comprised of two secretory systems,
exocrine and endocrine, that regulate two major physiological processes: digestion and
glucose metabolism. The endocrine pancreas consists of four specialized cell types that
are organized into compact islets embedded within acinar tissue (Figure 5). These cells
secrete hormones into the bloodstream. PP and delta cells produce pancreatic
polypeptide (PP) and somatostatin, respectively. The alpha and beta cells regulate the
usage of glucose through the production of glucagon and insulin, respectively
(Bardeesy et al. 2002).
As important as the liver, the pancreas plays a critical role in regulating
glucose homeostasis (Felig et al. 1976; Rasmussen et al. 1990; Schinner et al. 2005). In
vivo studies performed in our laboratory found cutaneous CPF exposure caused rat
12

pancreatic tissue damage (Rutherford and Cool, unpublished data). Elevated levels of
monocyte and leukocyte infiltration into pancreas suggested inflammation. Increased
inflammatory mediators such as TNF-α and IL-1 further support this conclusion.
Although pancreatic β-cells are responsible for secreting insulin in response to glucose,
many studies on OP-induced pancreas toxicity have only focused on acinar cell injury
related pancreatitis (Dressel et al. 1979; Moore et al. 1981; Dagli et al. 1983; Frick et
al. 1987; Goodale et al. 1993; Gulalp et al. 2007). So far no studies have investigated
the direct effect of CPF on pancreatic β-cell viability.
CPF and Insulin Secretion
Organophosphate pesticides have been investigated for their interruption of insulin
secretion. The pesticide, diazinon, was found to inhibit glucose-stimulated insulin
secretion from the isolated islets in rats (Pourkhalili et al. 2009). Another study from
Abdollahi et al. found that hand-picked islets treated with 200 and 400 ppm malathion
for 4 weeks showed decreased glucose-stimulated insulin secretion up to 69.6%
(Abdollahi et al. 2004). More importantly, data from our laboratory found that there
was a significant decrease in pancreatic insulin content and hyperglycemia in
CPF-treated rats, which couples CPF toxicity with hyperglycemia and possibly
diabetes (Rutherford and Cool, unpublished data).
Insulin secretion by pancreatic β-cells is a highly-regulated process, from
transcription to translation, peptide modification and finally secretion. Any deviation
from this pathway can result in conditions that lead to insulin secretion disorders.
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FIG. 5. Endocrine pancreas
This drawing shows the relative size and distribution of cells in a normal pancreas.
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Insulin is a heterodimeric protein with a 21 amino acid A-chain and a 30 amino acid
B-chain linked by two disulfide bonds (Ryle et al. 1955). The insulin gene however
encodes a larger molecule, preproinsulin (Sures et al. 1980; Ullrich et al. 1980) (Figure
6).
From preproinsulin to insulin, post-translational processing is necessary in
order to achieve maturation. Preproinsulin contains a signal sequence at its N-terminus,
an A-chain, B-chain C peptide (Ryle et al. 1955). The A and B-chains are linked by
disulfide bonds. The signal peptide is to direct the protein to the lumen of the
endoplasma reticulum and then is cleaved by signal peptidase to form proinsulin (Dev
et al. 1990; Davidson 2004). During maturation, a critical step is the cleavage of
proinsulin at paired-basic amino acid residues by specific proteinases (Docherty et al.
1982). The prohomone convertase 1/3 (PC1/3) and 2 (PC2) are identified as the
enzymes responsible for cleavage of proinsulin at paired-basic amino acid sites, while
PC1 cleaves at the B-C junction and PC2 cleaves at the A-C junction (Figure 6 and 7)
(Roebroek et al. 1986; Mizuno et al. 1988; Fuller et al. 1989; Seidah et al. 1990;
Smeekens et al. 1990; Nakayama et al. 1991).
Conversion of proinsulin to insulin occurs mainly in the Golgi and insulin
secretory granules (Steiner et al. 1967; Sorenson et al. 1970; Kemmler et al. 1973; Orci
et al. 1973; Hutton et al. 1982; Docherty et al. 1983). Secretory granules have an acidic
internal pH (between 5.0 and 6.0) and a high concentration of free calcium (1 to 10 mM)
(Hutton 1984). PC1 is synthesized as a precursor, preproPC1. There are 5 domains
within the precursor: an N-terminal signal peptide; a prosequence flanked by basic
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residues; a catalytic domain having the typical serine protease catalytic triad; a Homo B
domain for folding and a C-terminal helix domain (Muller et al. 1999) (Figure 8).
The 87 KDa proPC1to the 84 KDa form occurs in the endoplasmic reticulum by
autocatalysis (Goodman et al. 1994; Zhou et al. 1994). After delivery to secretory
granules, further cleavage in the C-terminal region results in the mature 66 KDa form
(Zhou et al. 1994). It is enzymatically more active than the 84 KDa form. Disruption of
the PC1 gene could cause multiple neuroendocrine and endocrine precursor-processing
defects (Zhu et al. 2002).
PC2 is also synthesized as a precursor. In contrast to PC1, PC2 prosequence
cleavage occurs in the late Golgi and secretory granules instead of in the endoplasmic
reticulum (Guest et al. 1992; Zhou et al. 1994). Newly synthesized PC2 folds quite
slowly, taking approximately 1 h to exit from endoplasmic reticulum (Guest et al. 1992;
Creemers et al. 1996). The 76 KDa proPC2 conversion to the 66 KDa active enzyme is
also autocatalytic and the activation requires an acidic pH (Lamango et al. 1999). One
unique feature of proPC2 is that a specific chaperone, 7B2 is required to facilitate
proPC2 maturation (Braks et al. 1994; Zhu et al. 1995). As PC1/3 and PC2 are
responsible for the cleavage of proinsulin at paired basic amino acids (Figure 7),
modifications that can cause alterations on PC enzyme activities will disrupt insulin
maturation and further secretion.
The primary target of OPs is inhibition of AChE via phosphorylation of the
catalytic triad in the AChE enzyme molecule (Figure 8). There are many secondary
targets affected by OPs (Figure 4).
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FIG. 6. Primary structure of human preproinsulin
Preproinsulin comprises a signal peptide ((clear ovals), B-chain (orange
orange ovals),
connecting peptide (purple
rple ovals), and A-chain (blue ovals). The pair of basic residues
is indicated (green ovals). The arrows repres
represent
ent the processing sites by PC1/3
PC1 and PC2.
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C -Chain
A -Chain

PC1 Cleavage site

PC2 Cleavage site
B -Chain

FIG. 7. Cleavage of proinsulin by PC enzymes
PC1 cleaves at B-C junction and PC2 cleaves at A-C junction of proinsulin to form
insulin and C peptide.
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OP’s effects are elicited through the phosphorylation of serine at the active site. AChE
is a serine hydrolase enzyme similar to other subtilisin enzymes (Casida et al. 2004).
PC1/3 and PC2, that are responsible for cleaving proinsulin to insulin, are also serine
hydrolases belonging to the subtilisin family (Seidah et al. 1999). As such, these
enzymes also have a catalytic triad similar to AChE, i.e., Asp, His, Ser (Figure 8) with
serine located at the active site. This triad is closely related to that of, AChE, i.e., Glu,
His, Ser. This relationship leads to the hypothesis that organophosphate compounds
will inhibit the PC enzymes in a fashion similar to acetylcholinesterase. If OPs were to
affect the catalytic triad in the proinsulin processing enzymes similar to how it affects
AChE, then they could have an effect on the processing of proinsulin to insulin, i.e.,
insulin maturation and secretion. However, there is no information available regarding
the effects of CPF on insulin secretion. If insulin secretion is affected by CPF, is the
impairment because of the inhibition of prohormone convertase by CPF? Either an
alteration in the viability of pancreatic β-cells, or disruption of insulin secretion by CPF,
would have deleterious effects on insulin-glucose regulation, providing an additional
reason for OP-caused hyperglycemia.
Diabetes mellitus is a major health problem characterized by hyperglycemia
resulting from defects in insulin secretion and/or action, currently affecting over 170
million people world-wide and prospectively affecting over 365 million by 2030
(Rathmann et al. 2004). Environmental factors are known to account for the
development of diabetes (Yoon et al. 1987; Ferner 1992). With OPs adverse effects on
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FIG. 8. Structure comparison of acetylcholinesterase and PC enzymes.
CPO phosphorylates AChE enzyme molecule at the catalytic triad Glu-His-Ser,
whereas PC enzymes also have a catalytic triad similar to AChE, i.e., Asp-His-Ser with
serine located at the active site.
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glucose metabolism and deleterious effects on pancreatic β-cells, widely used
organophosphate pesticides might be an additional factor contributing to the
development of diabetes. This proposal is to study the cytotoxicity of CPF on
pancreatic β-cells and possible effects on their function, insulin secretion.
The RIN-m5f (RIN) cell line was chosen as a model cell line to study the effects of
CPF on pancreatic β-cells. RIN cell line derives from a rat tumor pancreatic islet. It
secretes insulin and its insulin secretory response is similar to normal islets. Many
secretagogues have been reported to stimulate insulin secretion in RIN cells, including
glucose, potassium, glucagon and calcium (Bhathena et al. 1984; Chen et al. 1994;
Santangelo et al. 2007; Mao et al. 2009). For the studies presented here, we used
glucose and potassium as secretagogues.
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Hypothesis:
Chlorpyrifos causes cytotoxicity in insulin producing RIN-m5f β-cells by induction of
cell apoptosis and by interfering with insulin secretion and maturation through
inhibition of PC enzyme activity.

Specific Aim 1: Test the hypothesis that chlorpyrifos induces RIN-m5f cell apoptosis.
Specific Aim 2: Test the hypothesis that chlorpyrifos interferes with insulin secretion
and maturation through inhibition of PC enzyme activity.
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Materials and Methods
Chlorpyrifos Preparation
CPF was prepared in acetonitrile at 200 mM and serial dilutions made from 100
mM to 5 mM, with a final concentration of 5-200 µM CPF in 0.1% acetonitrile.
Cell Culture Medium
RIN cells were grown in RPMI 1640 containing 10% fetal bovine serum (FBS):
RPMI 1640 medium with 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 4.5 g/L
glucose, 10 mM HEPES, 1.0 mM sodium pyruvate and 10% FBS.
On the day of the experiment(s), RIN cells were incubated with CPF in the
presence of serum free media RPMI 1640 containing 0.1% bovine serum albumin
(BSA): RPMI 1640 medium with 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 4.5
g/L glucose, 10 mM HEPES, 1.0 mM sodium pyruvate and 0.1% (w/v) BSA.
Cell Culture
RINm5f (RIN) cells were obtained from ATCC. Cells were maintained at 37°C in 5%
CO2 incubator. Medium was changed every 3 days. When cells reached 80%
confluence, cells were split with 0.25% (w/v) Trypsin-0.53 mM EDTA solution and
plated in new T75 flasks.
MTT Assay
We utilized the Vybrant® MTT Cell Proliferation Assay Kit from Invitrogen to
quantify

cell

viability.

This

assay

measures

3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl

tetrazolium

the

reduction
bromide

of

yellow

(MTT)

by

mitochondrical succinate dehydrogenase to form an insoluble, dark purple formazan
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product. The cells are then solubilized with an organic solvent i.e., 100% DMSO. The
released solubilized formazan is then measured spectrophotometrically. Levels of
activity reflect the viability of the cells since MTT reduction can only occur in
metabolically active cells. The MTT assay is widely used for drug action, cytotoxic
agents and screening other biologically active compounds.
For determination of CPF on RIN cell viability, RIN cells (5 x104) were seeded in
96 well plate and maintained in RPMI 1640 medium containing 10% FBS until cells
reached 80% confluence. The medium then was replaced with RPMI 1640 medium
containing 0.1% BSA. Cells were treated with chlorpyrifos at 0 (0.1% acetonitrile as a
control), 5, 10, 25, 50, 100 and 200 µM for 2, 4 and 16 hr at 37°C in a 5% CO2 incubator.
MTT (10 µl) was added followed by incubation for 4 hr. Then 100 µl DMSO was added
and mixed thoroughly with the cells. The absorbance was measured at 570 nm.
Cell Apoptosis Assay
CPF induced-apoptosis in RIN cells was detected by a Cell Death Detection
ELISA Kit from Roche Applied Science. Apoptosis is the most common form of
eukaryotic cell death. It is characterized by membrane blebbing, cytoplasm
condensation and DNA fragmentation by activated endogenous endonuclease. The
cleavage of double stranded DNA appears at the internucleosomal linker region and
generates mono- and oligonucleosomes. The capture of the mono- and
oligonucleosomes in the cytoplasm of the apoptotic cell is due to the fact the DNA
fragmentation occurs before plasma membrane breakdown. This experiment was a
quantitative determination of cytoplasmic histone-associated DNA fragments (mono24

and oligonucleosomes).
The detection has several stages: first, anti-histone antibodies were fixed on the
wall of a microplate; second, non-specific binding sites were saturated by treatment
with incubation buffer (blocking buffer); third, nucleosomes contained in the sample
were bound to the immobilized anti-histone antibody via their histone components;
fourth, anti-DNA-peroxidase (POD) that reacts with the DNA of the nucleosome was
added; fifth, unbound peroxidase conjugate was removed by washing; sixth, the
amount of peroxidase retained in the immunocomplex was determined by reacting
with ABTS (2,2-azino-di-[3-ethylbenzthiazoline sulfonate]) as a substrate (Figure 9).

FIG. 9. Components of Cell Death Detection ELISA

Cells were seeded in 24-well plates at 1X105 per well and maintained in RPMI
1640 medium containing 10% FBS until cells reached 80% confluence. Medium was
then replaced with RPMI 1640 medium containing 0.1% BSA. Cells were treated with
chlorpyrifos at 0 (0.1% acetonitrile as a control), 5, 10, 25, 50, 100 and 200 µM for 2, 4
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and 16 hr at 37°C in a 5% CO2 incubator. Both cells (by cell scrapper) and medium
were then transferred to new tubes and centrifuged at 200 x g for 5 min. The supernatant
was discarded and the cell pellet was resuspend in 1 ml culture medium followed by
centrifugation at 1500 x g for 1 min. The cell pellet was resuspended with 500 µl
incubation buffer and the mixture incubated for 30 min at room temperature. The lysate
then was centrifuged at 20,000 x g for 10 min, after which 400 µl of the supernatant
(cytoplasmic fraction) was carefully removed and saved. The supernatant was diluted
1:10 with incubation buffer. Supernatant (100 µl) was added into MP-modules
precoated with anti-histone. The MP-modules were covered tightly with adhesive cover
foil and incubated for 90 min at room temperature. The solution then was removed
thoroughly and the wells were rinsed three times with 300 µl washing solution per well.
The washing solution was removed carefully followed by adding 100 µl of conjugate
solution into each well, except the blank position. MP-modules were tightly covered
with adhesive cover foil and incubated for 90 min at room temperature. The solution
then was removed and the wells were rinsed 3 times with 300 µl washing solution per
well. After the wells were empty, substrate solution (100 µl) was added into each well.
The MP-modules were then incubated on a shaker for about 15 min until a green color
developed and measured using spectrophotometer at 405 nm against substrate solution
as a blank.
This apoptosis method is very sensitive. The exact detection limit in different cells
is dependent on the kinetics of cell death and the agent used to induce cell death. For
example, in HL60 cells, treated with 0-4 µg/ml camptothecin (CAM) for 4 hr, the
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immunoassay allows the detection of mono-and oligonucleosomes in the cytoplasmic
fraction of 50 cells.
Cell necrosis assay
Necrosis is characterized by increased ion permeability of the plasma membrane
leading to cell swelling and rupturing the plasma membrane. RIN cell death will also be
evaluated with a Cytotoxicity Detetion Kit for LDH from Roche Applied Science. It is a
non-radioactive alternative to the [3H]-thymidine release assay and the [51Cr]-release
assay

based

on

measurement

of

LDH

activity

released

from

plasma

membrane-damaged cells.
RIN cells were adjusted to 5 x 104/200 µl with RPMI medium containing 0.1%
BSA in 96 well plates. No cells were added to wells for background control and
substance (CPF) control. The cells were incubated overnight in an incubator at 37°C in
5% CO2 to allow the cells to adhere tightly. The next day, the assay medium was
removed from the cells to remove LDH activity released from the cells and was
replaced with 200 µl fresh medium containing 0, 5, 10, 25, 50, 100 or 200 µM CPF. For
background control, 200 µl assay medium was added; for high control, 100 µl medium
containing 200 µM CPF and 100 µl 2% Triton X-100 were added; for substance control,
200 µl medium containing 200 µM CPF was added (Table 2). After incubation for 2, 4
and 16 hr, 100 µl/well supernatant was carefully removed and transferred into a new
96-well flat bottom microplate. Reaction mixture 100 µl was added to each well and
incubated for 30 min at room temperature (protecting from light). The LDH activity
then was measured by a plate reader at 490 nm.
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Table 2 LDH Experiment Design
Cells volume in
Contents of the
well

the
Assay medium

corresponding
0.1% acetonitrile

Triton X-100
soluction (2% in

Test substance

assay medium)

(200 µM CPF) µl

medium µl
Background

µl

200

-

-

-

Low control

-

200

-

-

High control

-

100

100

-

-

-

-

200

-

200

-

-

-

200

-

-

-

200

-

-

-

200

-

-

-

200

-

-

-

200

-

-

control

Substance
control
5 µM CPF
treatment
10 µM CPF
treatment
25 µM CPF
treatment
50 µM CPF
treatment
100 µM CPF
treatment
200 µM CPF
treatment

Assay medium: 0.1% acetonitrile RPMI medium containing 0.1% BSA
Background control: 200 µl assay medium to triplicate wells
Low control: spontaneous LDH release
High control: maximum LDH release
Cell toxicity by necrosis was calculated as follows:
Cytotoxicity (%)=(exp. value - low control)/ (high control - low control)*100
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Insulin Secretion
RIN cells (1X105) were seeded in 24-well plates and maintained in RPMI 1640
medium containing 10% FBS until cells reach 80% confluence. The medium then was
replaced with RPMI 1640 medium containing 0.1% BSA. Cells were treated with
chlorpyrifos for 2, 4 and 24 hr. Cells then were washed with KRBH buffer ( 0.1% BSA,
125 mM NaCl, 4.74 mM KCl, 1 mMCaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 5 mM
NaHCO3 and 25 mM HEPES, pH 7.4) three times. Then basal insulin secretion was
analyzed by incubation with KRBH buffer containing 2.8 mM glucose for 0.5 hr. After
collecting the medium, KRBH buffer containing either 25 mM glucose or 50 mM
potassium chloride was incubated for 1 hr. The stimulated insulin medium was then
collected for detection. The cells then were lysed with 300 µl 0.1 N HCl and were
transferred to a new tube followed by centrifugation at 13,000 rpm for 20 min at 4°C
and supernatant collection. Basal, stimulated and extracted cell protein were stored at
-80°C until use.
Insulin Detection by ELISA assay
The basal, stimulated and extracted RIN cell proteins were all analyzed for insulin
using an ALPCO rat insulin ELISA kit. The assay is a sandwich type immunoassay.
Monoclonal antibodies specific for insulin are immunoblized to the 96-well microplate.
After standards, controls and samples containing insulin are added to the wells, another
insulin antibody which is labeled with a horseradish peroxidase enzyme (Conjugate) is
added. As a result, insulin molecules are sandwiched between the solid phase of the
plate and the Conjugate. After incubation and washing, 3,3´,5,5´-tetramethylbenzidine
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(TMB) which is the substrate of the horseradish peroxidase, is added to show the blue
color. The intensity of the color generated is directly proportional to the amount of
insulin in the samples. Stop solution then is added to stop the reaction and change the
color from blue to yellow.
Insulin standard (10 µl), reconstituted control (10 µl) and the samples (10 µl) were
added into their respective wells followed by adding 75 µl of working strength
conjugate into each well. The plate was then incubated for 2 hr at room temperature on
a Belly Dancer (Stovall, Inc. Greensboro, N.C.). The microplate was then washed with
wash buffer for 6 times. TMB substrate 100 µl was added into each well and incubated
for 15 min on the Belly Dancer. Stop solution 100 µl then was added to stop the reaction
followed by reading the absorbance at 450 nm. The amount of insulin in the samples
was calculated based on the plotted standard curve. The unit of detected insulin was
ng/ml.
Proinsulin Detection by ELISA assay
Proinsulin detection was the same as insulin detection by the ELISA assay, except
that proinsulin antibodies were coated to the 96-well microplate. The assay is very
sensitive with the detection limit as low as several pmol/L (pM).
Western Blotting Analysis for Prohormone Convertase 1 and 2
Western Blotting was used to detect prohormone enzyme PC1 and PC2 expression
affected by CPF. RIN cells treated with various CPF concentrations for 4 hr were lysed
with lysis buffer containing 20 mM Tris HCl pH 8, 137 mM NaCl, 10% glycerol, 1%
glycerol, 1% NP-40 and 2 mM EDTA. The lysates were collected and homogenized
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followed by centrifugation at 4°C and 13,000 RPM for 15 min. Supernatants were
collected for protein determination by Bradford method using Biorad protein assay. As
the protein concentrations were very low, Ultacel YM membrane filter, YM-30 from
Millipore was used to concentrate the proteins. The microcon sample reservoir was
inserted into their corresponding vial and the sample proteins were added into the
sample reservoir. The attached cap was sealed and centrifuged 14,000 g for 24 min at
4°C. The vial and sample reservoir was then separated. The sample reservoir was
placed upside down in a new vial and centrifuged 3 min at 1,000 g to transfer
concentrate to the vial. The concentrated proteins were then analyzed by the Biorad
protein assay. One hundred µg proteins of each sample were loaded onto a 10-20%
Tris-HCl Biorad Criterion SDS gel. The separation conditions were 150 V for 90 min.
After separation, the proteins were transferred to a Citerion Gel PVDF blotting
membranes overnight at 18 V and 100 mA. Upon completion, the PVDF membranes
were blocked in Amersham membrane blocking agent (1.5 g blocking agent in 50 ml
1X PBS and 0.1% Tween-20 (PBS-T)) for 1 hr with gentle shaking. Membranes were
then incubated with either rabbit anti-prohormone convertase 1 (1:1000) (Millipore
Corporation) or rabbit anti-prohormone convertase 2 (1:50) (Millipore Coorporation)
primary antibodies in blocking agent overnight at 4°C. Upon completion of primary
antibody incubation, the PDVF membranes were washed in wash buffer 3 times
followed by addition of the secondary antibodies conjugated to horseradish peroxidase
in wash buffer (1: 20,000) for 1 hr. Following the wash, membranes were incubated
with the enhanced chemiluminescence (ECL) substrate (Pierce) and imaged using a
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Fuji FLA-5100 PhosphorImager and Image Guage software.
Detection of Prohormone Convertase 2 Activity
PC2 enzyme activity was determined using a fluorescent substrate. PC enzymes
are able to cleave at paired basic amino acids site at the appropriate pH and ion
concentration. Upon cleavage, a fluorescent compound is released and detected by
fluorescence spectrophotometer at 360 nm excitation and 480 nm emission
wavelengths. The intensity of the released fluorescence is in proportion to PC enzyme
activity. In order to analyze a specific PC enzyme activity, an inhibitor of this enzyme is
added in parallel incubations. The PC enzyme activity then is calculated by subtracting
the activity with the inhibitor from the total PC enzyme activity. Currently, the only
available inhibitor is the PC2 enzyme inhibitor. The inhibitor is a peptide having the
same

amino

acid

sequence

of

7B2

C-terminal

peptide

(CT

peptide),

SVNPYLQGKRLDNVVAKK.
RIN cells 1x106 were treated with CPF for 4 hr followed by protein extraction in
200 µl lysis buffer (50 mM Tris-HCl pH 7.5 containing 1% Triton X-100, 10% glycerol
and protease inhibitor cocktail (Sigma-Aldrich). After homogenization, the lysate was
centrifuged at 13,000 RPM for 15 min at 4°C. Supernatants were collected and protein
concentrations were determined. Sample aliquots were stored at -80°C until further use.
Total

proteins

(30

µg)

from

cells

were

L-pGlu-Arg-Thr-Lys-Arg-7-amino-4-methylcoumarin

incubated
(Peptide

with

100

International)

µM
in

reaction buffer (100 mM sodium acetate, pH 5.0 and 2 mmol/L CaCl2 ) at 37°C for 100
min. In parallel, 1 µM CT peptide SVNPYLQGKRLDNVVAKK (dissolved in water,
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Synthesized by Biomatik), a PC2-specific inhibitor (Zhu et al, 1996), was added to the
reactions. A fluorescence spectrophotometer was used to monitor the release of
7-amino-4-methylcoumarin (AMC) every 10 min up to 50 min. The activity inhibited
by the presence of CT peptide was considered as PC2-specific activity.
The PC2 activity was calculated as follow,
PC2 activity=Fluorescence released from the substrate incubation without CT
peptide-fluorescence release from the substrate incubation with CT peptide.
PC2 Activity Detection by MALDI-TOF MS Analysis
Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry

(MALDI-TOF MS) is a novel technique in which a matrix and biomolecules such as
proteins, peptide are irradiated by laser pulses. The matrix absorbs most of the laser
energy to prevent unwanted fragmentation of the biomolecules. The ionized
biomolecules are accelerated in an electric field and enter the flight tube. During the
flight in this tube, different molecules are separated according to their mass to charge
ratio and reach the detector at different times. Therefore, each molecule yields a distinct
signal based primarily on the mass. The method is used for detection and
characterization of biomolecules with molecular masses between 400 and 350,000
Dalton. It is a very sensitive method, which allows the detection of low (10-15 to 10-18
mole) quantities of sample with an accuracy of 0.1 - 0.01 %.
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The reactions used for detecting fluorescent substrate cleavage by PC2 were used.
Matrix of 1 µl, 10 mg/ml 2, 5-dihydroxy benzoic acid (DHB) (60% acetonitrile, 10%
acetone and 0.3% Trifluoroacetic acid TFA), was mixed with 1 µl reactions and loaded
on the MALDI-TOF plate. After the samples dried, the samples were analyzed using a
Bruker MALDI-TOF MS with reflector mode. For each sample, 2000 accumulated
shots were collected.
Inhibitor Study for Apoptosis and Necrosis
As 50 µM of CPF at 4 hr showed more apoptosis and less necrosis on RIN cells, 50
µM and 4 hr exposure was chosen to study the possible roles of oxidative stress, p38,
JNK on RIN cell death. Different concentrations of anti-oxidant N-Acetyl-L-cysteine
(NAC), p38 inhibitor SB202190 and JNK inhibitor SP600125 were preincubated with
RIN cells for 30 min.
For the NAC studies, 200 mM, 100 mM and 50 mM stock NAC (1000 times as
final concentrations) were prepared in PBS. Experiment groups were set as below
(Table 3).

Table 3 Antioxidant NAC Experimental Design

NAC

__

+

__

+

+

+

(concentrations)

(0.1%PBS)

(200 µM)

(0.1%PBS)

(50 µM)

(100 µM)

(200 µM)

CPF

__

__

+

+

+

+

(concentrations)

(0.1%acetonitirle)

(0.1%acetonitrile)

(50 µM)

(50 µM)

( 50 µM)

(50 µM)

For p38 inhibitor studies, 5 mM, 10 mM and 20 mM SB202190 (1000 times as
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final concentrations) were prepared in ethanol. Experiment groups were set as below
(Table 4).

Table 4 P38 Inhibitor Experimental Design

SB202190
(concentrations)
CPF
(concentrations)

__
(0.1%ethanol)

+

__

+

+

+

(20 µM)

(0.1%ethanol)

(5 µM)

(10 µM)

(20 µM)

__

__

+

+

+

+

(0.1%acetonitirle)

(0.1%acetonitrile)

(50 µM)

(50 µM)

( 50 µM)

(50 µM)

For JNK inhibitor studies, 5 µM, 10 µM and 20 µM SP600125 were prepared as
final concentrations in DMSO. Experiment groups were set as below (Table 5).

Table 5 JNK Inhibitor Experimental Design

SP600125
(concentrations)
CPF
(concentrations)

__

+

__

+

+

+

(0.1% DMSO)

(20 µM)

(0.1%DMSO)

(5 µM)

(10 µM)

(20 µM)

__

__

+

+

+

+

(0.1%acetonitirle)

(0.1%acetonitrile)

(50 µM)

(50 µM)

( 50 µM)

(50 µM)

Note: the concentrations in parentheses were final concentrations.
Following the treatment, apoptosis and necrosis experiments were performed.
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Results
Specific Aim 1
Cytotoxicity detection by MTT
To determine CPF cytotoxicity, RIN cells were treated for 2, 4 and 16 hr with
various concentrations of CPF or with the acetonitrile vehicle (0.1% final
concentration). Cell viability was analyzed by using the MTT assay. CPF caused doseand time-dependent reduction RIN viability at concentrations greater than 50 µM at 2
hr, 4 hr and 16 hr (Figure 10). The results suggest that CPF induces RIN cell
cytotoxicity.
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FIG. 10. CPF decreases MTT metabolism in RIN cells. RIN cells were treated with
CPF at 0 (0.1% acetonitrile as a control), 5, 10, 25, 50, 100 and 200 µM for 2, 4 and 16
hr. The cells were incubated with MTT for 4 hr followed by incubation with DMSO.
The absorbance was measured at 570 nm. Results were expressed as percent cell
viability. Data is representative of three independent experiments. Statistical analysis
was performed using Two-Way ANOVA. Bonferroni test was used for Post-hoc
comparison. N=3 ** denotes p< 0.01 vs. control.
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Cell apoptosis Assay
To determine whether apoptosis was responsible for the decrease in RIN cell
viability, we measured markers of apoptotic cell death. The results indicated that CPF,
caused a progressive, dose-related increase in apoptosis with respect to the untreated
controls as measured at 4 and 16 hr post-exposure (Figure 11). CPF at ≥ 50 µM
increased apoptosis ≈4 fold after 4 and 16 hr treatment. In contrast, 2 hr post-exposure
to 50 µM CPF did not induce a significant increase in apoptosis. Two hr exposure to
100 and 200 µM did produce a significant effect.
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FIG. 11. CPF induces RIN cell apoptosis. RIN cells were treated with CPF at 0 (0.1%
acetonitrile as a control), 5, 10, 25, 50, 100 and 200 µM for 2, 4 and 16 hr. The Cell
Death ELISA Kit was used for detecting apoptosis. Results were expressed as fold of
control. The values are expressed as the mean±SEM. Data is representative of three
independent experiments. Statistical analysis was performed using Two-Way ANOVA.
Bonferroni test was used for Post-hoc comparison.
** denotes p< 0.01 vs. control.
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Cell necrosis assay
In addition to apoptosis, necrosis is another type of cell death. The apoptosis
experiment showed that CPF could induce apoptotic cell death. However, there is no
reason to exclude that RIN cells could die through necrosis. LDH released from the
plasma membrane was used as a test for necrosis. The occurrence of necrotic cell death
appeared to be at 50 µM CPF and was time and dose-dependent (Figure 12). At 50 µM,
necrosis increased in RIN cells from 8.9±1.3% at 2 hr to 17.14±6.9% at 4 hr and
20.81±1.6% at 16 hr in comparison to control (Figure 12).
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FIG. 12. CPF induces necrotic cell death in RIN cells. RIN cells were treated with CPF
at 0 (0.1% acetonitrile as a control), 5, 10, 25, 50, 100 and 200 µM for 2 (A), 4 (B) and
16 hr (C). Cellular necrosis was determined using the Roche LDH kit. Results were
expressed as percent cell death. The values are expressed as the mean±SEM. Data
represents of three independent experiments. Statistical analysis was performed using
Two-Way ANOVA. Bonferroni test was used for Post-hoc comparison.
** Denotes p< 0.01 vs. control.
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The percentage of apoptosis and necrosis of RIN cells treated with CPF
Based on the results, CPF induces two types of cell death, apoptosis and necrosis.
In order to determine the proportion of each type of cell death, we made the assumption
that cell viability assay (MTT experiment) accurately reflects cell death. Table 6
summarizes the types of cell death and their corresponding percentage in the whole
population. The table indicates that the majority of cell death was due to apoptosis but
necrosis also contributed to a significant amount of cell death.
Table 6 Comparison of cell death affected by CPF
CPF concentration

50

100

200

Cell death type

A

N

A

N

A

N

2 hr

7.89

8.90

47.33

14.50

44.31

18.70

4 hr

24.65

17.14

43.98

20.39

45.22

20.09

16 hr

54.04

20.81

56.07

22.77

56.38

27.43

“A” represents apoptosis whereas “N” represents necrosis.
The numbers represent a percentage of the total number of cells counted, both alive and
dead. Thus the percent live cells would be the difference between total cell counts
minus apoptotic + necrotic cell counts.
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Antioxidant N-Acetyl-L-cysteine (NAC) on Cell Viability
To explore the potential mechanisms of CPF induced cell death, inhibitors were
used to investigate their effects on RIN cell death. The mechanism of apoptosis has
been well studied for a long time, whereas very limited work has been done on the
mechanism of necrotic cell death. We chose a CPF concentration and exposure duration
that would cause more RIN cell death by apoptosis and less by necrosis. As such,
further characterization of CPF toxicity was performed using 50 µM CPF and 4 hr
exposure. It is well demonstrated that pesticides could cause the production of
oxidative stress. We then tested whether an oxidative stress inhibitor, i.e. NAC, could
suppress cell death, either apoptosis or necrosis. In order to determine the specificity of
NAC on the alteration of either type of cell death, we used 3 different concentrations of
NAC (50, 100 and 200 µM). Our results suggest that NAC had dose-dependent
protection of CPF-induced RIN apoptosis. At 200 µM, NAC significantly inhibited
CPF-caused cell apoptosis by 22.5% (Figure 13). When the effect of NAC on
CPF-induced necrosis was tested, there was no significant influence at any
concentration. NAC itself induced increased RIN cell necrotic cell death and did not
exhibit a protective effect on CPF-induced necrosis (Figure 14). Our results indicate
that antioxidant NAC may specifically protect RIN cells from injury associated via
apoptosis, but not necrosis as induced by CPF.
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FIG. 13. The effects of antioxidant N-Acetyl-L-cysteine (NAC) on CPF-induced RIN
cell apoptosis. The RIN cells were pretreated with PBS (vehicle for NAC, column 1 and
column 3), 200 µM NAC (column 2), and 3 different concentrations of antioxidant
N-Acetyl-L-cysteine (NAC) (50, 100 and 200 µM; column 4, 5 and 6 respectively) for
30 min followed by acetonitrile (vehicle for CPF, column 1 and column 2) or 50 µm
CPF treatment (column 3, 4, 5, and 6) for 4 hr. The Cell Death ELISA kit was used for
detecting apoptosis. Results were expressed as fold of control. The values are expressed
as the mean±SEM. Data is representative of three independent experiments. Statistical
analysis was performed using One-Way ANOVA. Tukey test was used for Post-hoc
comparison. * Denotes p<0.05 compared to CPF only group (column 3).
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FIG. 14. The effects of antioxidant N-Acetyl-L-cysteine (NAC) on CPF-induced RIN
cell necrosis. The cells were pretreated with PBS (vehicle for NAC, column 1 and
column 3), 200 µM NAC (column 2), and 3 different concentrations of antioxidant
N-Acetyl-L-cysteine (NAC) (50, 100 and 200 µM; column 4, 5 and 6 respectively) for
30 min followed by acetonitrile (vehicle for CPF, column 1 and column 2) or 50 µm
CPF treatment (column 3, 4, 5, and 6) for 4 hr. Cellular necrosis was determined using
the Roche LDH Kit. Results were expressed as percent cell death. The values are
expressed as the mean±SEM. Data is representative of three independent experiments.
Statistical analysis was performed using One-Way ANOVA.
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Inhibition of p38 and JNK MAPK Kinases on Cell Viability
Activation of c-Jun N-terminal kinases/stress-activated protein kinase (JNK/SAPK,
JNK) and p38 MAPK is associated with apoptosis, and inhibition of their activation
rescues cells from apoptotic death (Chang et al. 2001; Cai et al. 2006; Zhou et al. 2006;
Tanel et al. 2007). To ascertain whether JNK and p38 pathway mediated CPF-induced
apoptosis and necrosis, RIN cells were exposed to CPF in the presence and absence of 2
inhibitors, the p38 inhibitor SB202190, or the JNK inhibitor SP600125, for 4 hr. The
mechanistic pathways were explored briefly using two inhibitors. For the p38 inhibitor,
SB202190, the concentrations used were 5, 10 and 20 µM. For the JNK inhibitor,
SP600125, 5, 10 and 20 µM were used. The p38 inhibitor SB202190 at 5, 10 and 20 µM
significantly reduced CPF-induced apoptosis 1.28, 1.68 and 2.46 fold respectively
(Figure 15). However, SB202190 failed to inhibit the necrosis effects of CPF (Figure
16). JNK inhibitor SP600125 also significantly reversed CPF-induced apoptosis 2.12
and 2.27 fold at 10 and 20 µM respectively (Figure 17). In contrast to SB202190,
SP600125 also showed a protective effect on CPF-induced cell necrosis. Cell necrosis
reduced from 15.04% to 9.6% and 10.28% respectively at 10 and 20 µM concentrations
(Figure 18). These results indicated that p38 mediates pathways which may induce RIN
cell apoptosis, but not necrosis. JNK mediates pathways which induce not only RIN
cell apoptosis, but also necrosis.
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FIG. 15. The p38 inhibitor SB202190 inhibits CPF-induced RIN cell apoptosis. The
cells were pretreated with ethanol (vehicle for SB202190, column 1 and 3), 20 µM
SB202190 (column 2), and 3 different concentrations of SB202190 (5, 10 and 20 µM;
column 4, 5 and 6 respectively) for 30 min followed by acetonitrile (vehicle for CPF,
column 1 and column 2) or 50 µM CPF treatment (column 3, 4, 5, and 6) for 4 hr. The
Cell death ELISA Kit was used for detecting apoptosis. Results were expressed as fold
of control. The values are expressed as the mean±SEM. Data is representative of three
independent experiments. Statistical analysis was performed using One-Way ANOVA.
Tukey test was used for Post-hoc comparison. * Denotes p<0.05 and ** denotes p< 0.01
vs. CPF only group.
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FIG. 16. The effects of p38 inhibitor SB202190 on CPF-induced RIN cell necrosis. The
cells were pretreated with ethanol (vehicle for SB202190, column 1 and column 3), 20
µM SB202190 (column 2), and 3 different concentrations of SB202190 (5, 10 and 20
µM; column 4, 5 and 6 respectively) for 30 min followed by acetonitrile (vehicle for
CPF, column 1 and column 2) or 50 µM CPF treatment (column 3, 4, 5, and 6) for 4 hr.
Cellular necrosis was determined using the Roche LDH Kit. Results were expressed as
percent cell death. The values are expressed as the mean±SEM. Data is representative
of three independent experiments. Statistical analysis was performed using One-Way
ANOVA.
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FIG. 17. The JNK inhibitor SP600125 inhibits CPF-induced RIN cell apoptosis. The
cells were pretreated with DMSO (vehicle for SP600125, column 1 and column 3), 20
µM SB202190 (column 2), and 3 different concentrations of SP600125 (5, 10 and 20
µM; column 4, 5 and 6 respectively) for 30 min followed by acetonitrile (vehicle for
CPF, column 1 and column 2) or 50 µM CPF treatment (column 3, 4, 5, and 6) for 4 hr.
The Cell Death ELISA Kit was used for detecting apoptosis. Results were expressed as
fold of control. The values are expressed as the mean±SEM. Data is representative of
three independent experiments. Statistical analysis was performed using One-Way
ANOVA. Tukey test was used for Post-hoc comparison. ** Denotes p< 0.01 vs. CPF
only group (column 3).
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FIG. 18. The JNK inhibitor SP600125 inhibits CPF-induced RIN cell necrosis. The
cells were pretreated with DMSO (vehicle for SP600125, column 1 and column 3), 20
µM SB202190 (column 2), and 3 different concentrations of SP600125 (5, 10 and 20
µM; column 4, 5 and 6 respectively) for 30 min followed by acetonitrile (vehicle for
CPF, column 1 and column 2) or 50 µM CPF treatment (column 3, 4, 5, and 6) for 4 hr.
Cellular necrosis was determined using the Roche LDH Kit. Results were expressed as
percent cell death. The values are expressed as the mean±SEM. Data is representative
of three independent experiments. Statistical analysis was performed using One-Way
ANOVA. Tukey test was used for Post-hoc comparison. * Denotes p< 0.05 vs. CPF
only group (column 3).
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Specific Aim 2
Basal insulin and proinsulin
Insulin secretion reflects β-cell function. Proinsulin is the prohormone precursor
of insulin. This specific aim focused on β-cell secretion affected by CPF at lower
concentrations than lethal doses. Three different time points (2, 4, 24 hr) and various
CPF concentrations (0, 5, 10, 25 µM) were chosen to evaluate basal secretion of insulin
(in the presence of 2.8 mM glucose). After 2, 4 and 24 hr incubation with different
concentrations of CPF, basal insulin secretion was unchanged compared to control cells
(Figure 19). Basal proinsulin secretion was detected at 4 hr post-exposure to CPF.
There was no significant change at any doses (Figure 20).
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FIG. 19. Effect of CPF on basal insulin secretion. Cells were treated with 0 (0.1%
acetonitrile as control), 5, 10 and 25 µM CPF for 2, 4 and 24 hr. Cells were then washed
with KRBH buffer three times. Basal insulin secretion was detected by incubating
KRBH buffer containing 2.8 mM glucose for 0.5 hr. The level of insulin in the culture
medium was analyzed by ELISA and normalized to ng/ml/min. Data represents three
independent experiments. Statistical analysis was performed using Two-Way ANOVA.
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FIG. 20. Effect of CPF on basal proinsulin secretion. RIN cells were treated with 0 (0.1%
acetonitrile as control), 5, 10 and 25 µM CPF for 4 hr. Cells were then washed with
KRBH buffer three times. Basal proinsulin secretion was detected by incubating KRBH
buffer containing 2.8mM glucose for 0.5 hr. The level of proinsulin in the culture
medium was analyzed by the ELISA normalized to pmol/L/min. Data represents three
independent experiments. Statistical analysis was performed using One-Way ANOVA.
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Stimulated Insulin and Proinsulin Secretion by Potassium
To verify whether CPF could cause a functional impairment of insulin secretion in
RIN cells, CPF-treated RIN cells were stimulated with a depolarizing concentration of
KCl (50 mM) for 1 hr following basal secretion. Insulin and proinsulin were both
analyzed. Our data showed that non-cytotoxic concentrations of CPF (10 and 25 µM)
significantly inhibited RIN cells insulin secretion in a dose- and time-dependent
manner at 4 hrand 24 hr (Figure 21). At concentrations as low as 5 µM, CPF inhibited
insulin secretion at 4 hr as well. Potassium-stimulated insulin secretion was 4 to 11-fold
more than the basal insulin secretion (Figure 21 and Table 7). If the ratio of stimulated
secretion to basal secretion is greater than one, then the secretory pathway is called a
regulated secretory pathway; if the ratio is equal or less than one, the secretory pathway
is called a constitutive secretory pathway. Our results verify that potassium-stimulated
insulin secretion is through the regulated secretory pathway (Table 7). CPF has an
adverse effect on regulated secretion of insulin in RIN cells at concentrations of 10 and
25 µM and exposure times of 4 and 24 hr (Table 7). In contrast, RIN cells showed a
significant reduction in potassium-stimulated proinsulin secretion to that of basal
proinsulin at all concentrations (Figure 22). However after 4 hr treatment with CPF,
there was significant increase in proinsulin secretion compared to control cells
(stimulated proinsulin). Potassium-stimulated proinsulin was 0.655, 0.809 and 0.814
fold of basal proinsulin (Table 8) which qualifies a constitutive secretory pathway.
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FIG. 21. Effect of CPF on potassium-stimulated insulin secretion. RIN cells were
treated with various CPF concentrations for 2, 4 and 24 hr. After collecting basal insulin,
cells were then stimulated with KRBH buffer containing 50 mM potassium for 1 hr,
followed by analyzing secreted medium. The level of stimulated-insulin in the culture
medium was analyzed by ELISA and normalized to ng/ml/min. Basal insulin secretion
from Figure 19 was drawn for comparison. Data represents three independent
experiments. Statistical analysis was performed using Two-Way ANOVA. Bonferroni
test was used for Post-hoc comparison. * p< 0.05 and ** p< 0.01 vs. control.
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Table 7 Insulin stimulation by potassium
CPF concentration

CPF exposure time

0

5

10

25

2 hr

11.135±0.929

8.782±1.366

7.805±0.975

8.681±2.446

4 hr

11.017±1.239

8.077±1.343

6.484±0.309*

6.534±0.374**

24 hr

10.431±1.171

6.903±1.100

4.619±0.484*

4.197±0.731**

Insulin Stimulation by Potassium = (stimulated/unstimulated)
Notes: Insulin secretion unit is ng/ml/ min. Statistical analysis was performed using
Two-Way ANOVA. Bonferroni test was used for Post-hoc comparison. * Represents
p<0.05 and ** represents p<0.01 compared to control group (0).
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FIG. 22. Effect of potassium-stimulated proinsulin secretion. RIN cells were treated
with 0 (0.1% acetonitrile as control), 5, 10 and 25 µM CPF for 4 hr. After collecting
basal proinsulin, cells were then stimulated with KRBH buffer containing 50 mM
potassium for 1 hr, followed by analyzing secreted medium. The level of
stimulated-proinsulin in the culture medium was analyzed by ELISA and normalized to
pmol/L/min. Basal proinsulin (4 hr) from Figure 20 was drawn for comparison. Data
represents three independent experiments. Statistical analysis was performed using
One-Way ANOVA. Tukey test was used for Post-hoc comparison.* Represents p< 0.05
vs. control.
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Table 8 Proinsulin stimulation by potassium
CPF concentration

CPF exposure time

4 hr

0

5

10

25

0.655±0.065

0.761±0.012

0.809±0.028

0.814±0.008

Proinsulin Stimulation by potassium= (stimulated insulin/basal insulin)
Statistical analysis was performed using One-Way ANOVA.
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Stimulated Insulin and Proinsulin Secretion by Glucose
Glucose is a physiological secretagogue for insulin secretion. We evaluated
glucose-stimulated (25 mM) insulin and proinsulin secretion after 4 hr incubation with
0, 5, 10 and 25 µM CPF following the basal insulin secretion. Our data showed that 25
mM glucose caused less insulin secretion than that of 50 mM potassium (Figure 23A
and Figure 21). Glucose-stimulated insulin secretion was significantly decreased in
RIN cells incubated with CPF for 4 hr, at all concentrations, compared to control
(Figure 23A) and the ratio of stimulated to basal insulin showed significant changes
(Table 9). Proinsulin secretion showed a similar pattern as 50 mM potassium
stimulation, i.e. reduced proinsulin secretion to that of basal (Figure 23B). The ratio of
stimulated proinsulin to basal proinsulin had an increased trend and showed
significance at 25 µM (Table 10).
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FIG. 23. Effect of glucose-stimulated insulin and proinsulin secretion. RIN cells were
treated with various CPF concentrations for 4 hr. After collecting basal insulin and
proinsulin, cells were then stimulated 25 mM glucose for 1 hr, followed by analyzing
secreted medium for insulin (A) and proinsulin (B). Basal insulin and proinsulin
secretion (4 hr) was drawn for comparison. The values are expressed as the mean±
SEM from three independent experiments. Statistical analysis was performed using one
way ANOVA. * p< 0.05 and ** p< 0.01 vs. control.
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Table 9 Insulin stimulation by glucose
CPF concentration

CPF exposure time

4 hr

0

5

10

25

2.057±0.095

1.656±0.103

1.516±0.094*

1.598±0.104*

Insulin Stimulation by Glucose = (stimulated insulin/basal insulin)

Table 10 Proinsulin stimulation by glucose
CPF concentration

CPF exposure time

4 hr

0

5

10

25

0.515±0.024

0.896±0.052

0.828±0.153

0.977±0.071*

Proinsulin Stimulation by Glucose = (stimulated proinsulin/basal proinsulin)
Notes: Insulin secretion unit is ng/ml/ min. Statistical analysis was performed using
One-Way ANOVA. Tukey test was used for Post-hoc comparison. * Represents p<0.05
compared to control group (0).
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Intracellular Insulin and Proinsulin After Potassium Stimulation
In order to have a complete picture of total insulin and proinsulin in the cells,
intracellular insulin and proinsulin were measured. Cells were treated with various
concentrations of CPF for different times followed by basal and 50 mM potassium
stimulation and then cellular total protein collection.
CPF-treated cells showed no significant difference in intracellular insulin except at
25 µM and 4 hr post-exposure (Figure 24). Further, intracellular proinsulin after 4 hr
treatment had no significant change (Figure 25).
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FIG. 24. Changes of intracellular insulin after 50 mM potassium stimulation. RIN cells
were treated with various CPF concentrations for 2, 4, and 24 hr. After collecting basal
and stimulated (50 mM potassium) insulin, cells were then lysed with 0.1 N HCl
followed by protein extraction. The level of insulin was analyzed by ELISA. The values
are expressed as the mean±SEM from three independent experiments. Statistical
analysis was performed using unpaired Two-Way ANOVA. Bonferroni test was used
for Post-hoc comparison. ** Represents p<0.01 vs. control.
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FIG. 25. Intracellular proinsulin after 50 mM potassium stimulation. RIN cells were
treated with various CPF concentrations for 4 hr. After collecting basal and stimulated
(50 mM potassium) proinsulin, cells were then lysed with 0.1 N HCl followed by
protein extraction. The level of proinsulin was analyzed by ELISA. The values are
expressed as the mean±SEM from three independent experiments. Statistical analysis
was performed using One-Way ANOVA.
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Intracellular Insulin and Proinsulin After glucose Stimulation
To verify whether after glucose stimulation the amount of intracellular insulin and
proinsulin had a similar pattern as that after potassium stimulation, RIN cells were
treated with various CPF concentrations for 4 hr followed by 2.8 mM glucose (basal)
and 25 mM glucose stimulation and then cellular proteins were extracted. CPF-treated
RIN cells showed decreases in intracellular insulin (Figure 26A). However, cellular
proinsulin did not show any significant changes (Figure 26B).
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FIG. 26. Intracellular insulin and proinsulin after glucose stimulation. RIN cells were
treated with various CPF concentrations for 4 hr. After collecting basal (2.8 mM
glucose) and stimulated (25 mM glucose) insulin and proinsulin, cells were then lysed
with 0.1 N HCl followed by protein extraction. The level of insulin (A) and proinsulin
(B) were analyzed by ELISA. The values are expressed as the mean±SEM from three
independent experiments. Statistical analysis was performed using One-Way ANOVA.
Tukey test was used for Post-hoc comparison. * Represents p< 0.05 and ** p<0.01 vs.
control.
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PC Enzyme Expression in RIN cells
Since our hypothesis links decreased insulin secretion and cellular content with
inhibited PC enzymes, we next determined PC enzyme expression in RIN cells in the
presence and absence of various CPF concentrations (5, 10, 25, 50, 100 and 200 µM) at
4 hr using western blotting. PC1 enzyme exhibited two bands in RIN cells (Figure
27A upper panel). The band at 164 kD represents proPC1 and the band at 115 kD
represents active PC1. RIN cells showed elevated expression of PC1 at concentrations
higher than 25 µM (Figure 27A 115 kDa). RIN cells treated with CPF had no change on
PC2 expression (Figure 27B). Our results indicated that PC 1 and PC 2 are expressed in
RIN cells and PC1 is up-regulated by CPF.
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FIG. 27. PC1 and PC2 expression in RIN cells. RIN cells were treated with various CPF
concentrations (0, 5, 10, 25, 50, 100, 200 µM) for 4 hr. Cells were then lysed and
proteins were extracted and quantified. Aliquots of the total lysate containing an
equivalent amount of protein (100 µg/lane) were used. Quantification data was
expressed as arbitrary units of intensity relative to β-actin. The values are expressed as
the mean ± SEM from three independent experiments. Statistical analysis was
performed using One-Way ANOVA. Tukey test was used for Post-hoc comparison.
* Represents p< 0.05 vs. control (0).
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PC2 Enzyme Activity
We provided evidence that two PC enzymes, PC1 and PC2, were present in RIN
cells. In addition, PC1 expression was altered by CPF. Decreased insulin levels can be
caused by decreased activities of PC enzymes, which convert proinsulin to insulin.
PC1/3 was not detected due to the lack of a specific inhibitor. To test whether the
activity of PC2 was affected by CPF, we analyzed PC2 activity using a synthetic
peptide substrate in the presence or absence of an inhibitor to PC2. At 0.1 and 5 µM
CPF, the slopes of the PC2 activity were not significantly different from control. On the
contrary, at concentrations from 10-200 µM CPF, there was a significant decrease in the
slopes, indicating inhibition of the PC2 enzyme activity (Figure 28).
To confirm that the peptide substrate and CT peptide inhibitor were present, we
analyzed the reaction mixture by mass spectrometry. A peak of 828 Dalton was
observed, characteristic of the substrate and a unique peak at 689 Dalton representative
of the cleaved portion of the substrate. A peak at 1773 Dalton was observed in the
“inhibited” samples indicating the CT peptide without the paired basic residues at the
C-terminals, i.e. KK. A separate spectrum showed that CT peptide peaks at 2029 Dalton
indicating its original peptide mass before the cell lysate was added (Figure 29).
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FIG. 28. PC2 enzyme activity determination after 4 hr exposure to CPF. RIN cells were
treated with 0 (0.1% acetonitrile as control), 0.1, 5, 10, 25, 50, 100, and 200 µM CPF for 4 hr.
Cells were then lysed and proteins were extracted. Total proteins (30 µg) of each sample
were incubated with PC2 reaction buffer in the presence and absence of CT peptide. The
activity inhibited by the presence of CT peptide was considered as a PC2-specific activity.
PC2 enzyme activity was expressed as fluorescence intensity. X- Axis represents minutes
after CPF treatment. Y- Axis represents fluorescence activity. The values are expressed as
the mean±SEM. Data represents three independent experiments. Comparisons of multiple
regression lines were performed using Regression Analysis. Contrast was used for Post-hoc
comparison. ** Donates p<0.01 vs. control.
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FIG. 29. Mass spectrometry analysis on PC2 enzyme activity and its inhibitor, i.e., CT
peptide. The upper spectrum indicated the PC2 activity in the presence of the substrate
(extracted from RIN cells treated with 200 µM for 4 hr). Molecular weight 828 Dalton
represents the substrate and 689 Dalton represents the cleaved substrate; the middle
spectrum indicated PC2 activity in the presence of the substrate and the CT peptide.
Molecular weight 1773 Dalton represents cleaved CT peptide; the lower spectrum
indicated in the presence of the substrate and the CT peptide only.
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Discussion
Chlorpyrifos-Induced Cell Death
CPF is an organophosphate pesticide that is used worldwide in agricultural and
non-agricultural applications. Thus, it is very important to continuous to evaluate its
toxicity. While effects on cholinesterase have been extensively studied, much less is
known about its potential toxic effects on the pancreas, especially pancreatic β-cells.
The goal of the first aim was to determine whether CPF could induce apoptosis in
pancreatic β-cells and secondly to try to determine the underlying mechanism(s) for
apoptosis. Our results suggest that CPF has both apoptotic and necrotic effects on RIN
cells. Other studies have shown that cytotoxicity via apoptosis and necrosis usually
appears at much higher doses, i.e. in the micromolar range (Nakadai et al. 2006;
Caughlan et al. 2004; Mense et al. 2006; Saulsbury et al. 2008). In contrast, the
concentration to inhibit AChE inhibition by CPF/CPO is within the nanomolar range.
This suggests that apoptosis and necrosis are not induced by AChE inhibition, but
through different mechanisms. In comparison to other cell lines (Table 1), the doses of
CPF used to cause RIN cell death are in the micromolar range.
It is commonly accepted that toxicity of CPF involves the formation of CPO, a
potent anticholinesterase inhibitor. However, some studies suggest that CPF is more
toxic than CPO (Nakadai et al. 2006). At 143 µM and 285 µM, CPF caused 5 times
more cell death than CPO in a human monocyte cell line U937 (Nakadai et al. 2006).
Caughlan et al. also found that CPO was only slightly more potent than CPF in inducing
cortical neuron apoptosis (Caughlan et al. 2004). The finding that CPF has the ability to
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inhibit axonal outgrowth in the presence of the CYP-450 inhibitor SKF-525A (Howard
et al. 2005) suggested that not only CPO, but also CPF injures neurons. A study by
Saulsbury et al. suggested that CPF-caused reduction in JAR cell viability was higher
than that of CPO (Saulsbury et al. 2008). The studies described above demonstrate that
specific cells have different sensitivities to CPF and CPO, and the cytotoxicity caused
by CPF cannot be solely explained by its activated metabolite, CPO. However,
potential correlations between AChE inhibition and CPF-induced apoptosis needs
further study. The mechanisms by which CPF causes apoptosis and necrosis are unclear.
The proportion of apoptosis to necrosis suggests that the apoptotic pathway is
predominant except at its lowest concentration (50 µM) and shorter time (2 hr) where
the percentage of cell death by apoptosis and necrosis was equal.
Oxidative Stress induction by CPF
Various studies have indicated that OPs may cause oxidative stress in vivo and in
vitro, as well as in humans (Ahmed et al. 2000; Akhgari et al. 2003; Bebe et al. 2003;
Sharma et al. 2005; Giordano et al. 2007). Oxidative stress generated by CPF possibly
is through disruption and/or depletion of endogenous antioxidants, formation of
reactive oxygen species, increased levels of oxidized glutathione (Giordano et al. 2007)
and alteration of gene expression corresponding to antioxidants, such as superoxide
dismutase and glutathione peroxidase (Slotkin et al. 2007). Previous studies have
suggested that antioxidants could protect against the oxidative stress induced by OPs
(Gultekin et al. 2001; Gupta et al. 2001; Karaoz et al. 2002; Oncu et al. 2002;
Cankayali et al. 2005). In our study, the antioxidant, NAC, showed a small but
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significant inhibition of CPF-induced apoptotic cell death. Necrosis was not inhibited
by NAC. These results suggest a correlation between CPF and oxidative stress-related
apoptosis.
Involvement of the JNK and p38 Pathway in CPF-Induced Cell Death
Transcription factors such as AP-1, p53 (Minden et al. 1997; Davis 2000) and
nontranscription factors such as Bcl-2 family members are closely related to apoptotic
cell death (Lin 2003). Various environmental stresses, such as oxidative, UV radiation,
heat shock, chemotherapeutic agents, and proinflammatory cytokines are able to
activate JNK. Substantial evidence indicates that JNK is an important proapoptotic
factor in oxidatively stressed cells (Aoki et al. 2002; Kharbanda et al. 2000; Yamamoto
et al. 1999; Lei et al. 2003; Putcha et al. 2003). While JNK is readily activated by ROS;
blocking JNK activation provides significant protection against apoptosis. Activated
JNK-induced apoptosis begins in mitochondria. Bcl-2 family members are believed to
link JNK and apoptosis in mitochondrial apoptosis. Active JNK induces cytochrome C
release from isolated mitochondria in a cell-free assay (Aoki et al. 2002) and when cells
are in stress, JNK translocates to the mitochondria (Kharbanda et al. 2000). Evidence
suggests that JNK induces apoptosis by regulating Bcl-2 family members. For example,
JNK phosphorylation inhibits the antiapoptotic function of Bcl-2 (Yamamoto et al.
1999) and enhances the proapoptotic Bcl-2 family member, Bim through
phophorylation (Lei et al. 2003; Putcha et al. 2003) along with conformational changes
and translocation of Bax (Lei et al. 2002; Tsuruta et al. 2004). Our data demonstrates
that the JNK inhibitor, SP600125 (20 µM) almost completely blocked CPF-induced
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apoptosis. This suggests that the JNK pathway is activated by CPF. As the inhibition of
oxidative stress by NAC was not able to completely block apoptosis, it would appear
that other factors besides oxidative stress are involved in JNK activation.
Oxidative stress is believed to have the ability to induce either apoptosis or
necrosis. However, why and how cells die from necrosis is far from clear. Apoptosis
and necrosis may or may not occur at the same time and at the same exposure dose.
Mense et al. (Mense et al. 2006) found that CPF caused LDH release in primary human
astrocytes at a concentration as low as 0.2 µM after 2 weeks treatment, whereas at 100
µM, CPF generated apoptosis as analyzed by TUNEL. However, the mode of cell death
is dependent on the cell type, the extent of oxidative stress, and the cell signaling
pathway elicited by ROS (Gardner et al. 1997; Troyano et al. 2003). In RIN cells, ROS
does not mediate CPF-induced necrotic cell death since the anti-oxidant NAC did not
inhibit RIN cell necrosis. However the result that the JNK inhibitor, SP600125,
partially blocks CPF-induced necrosis suggests that JNK may be involved in RIN
necrosis. Further work is needed to identify the molecular targets of JNK in
ROS-induced apoptotic and necrotic cell death.
P38 is also a MAPK family molecule. Along with JNK, it is preferentially
activated by cell stress-inducing signals, such as oxidative stress and toxic chemicals
(Davis 2000). P38 inhibition failed to attenuate CPF-induced placental cell apoptosis
(Saulsbury et al. 2008). Similarly, in rat cortical neurons, blocking p38 significantly
accelerated apoptotic cell death in the presence of CPF (Caughlan et al. 2004). In our
experiments, the p38 inhibitor, SB202190, partially blocked CPF-induced cell
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apoptosis suggesting that p38 acts via a pro-apoptotic pathway to mediate CPF-induced
RIN apoptosis. This implies that there are no absolute signaling pathways and the role
of activated p38 varies in different cells. Currently, there are very limited resources in
regard to the activation of p38 and the following molecular action of apoptosis. P38
induced apoptosis was reported to regulate Bax translocation (Shou et al. 2003). Bax
translocates from the cytosol to the mitochondria to disrupt mitochondrial membrane
potential and to heterodimerize with antiapoptotic Bcl-2 proteins to counteract their
actions. Similar to the mechanism in JNK-induced apoptosis, p38 was also found to
directly phosphorylate Bim at Ser-65 in sodium arsenite-induced apoptosis (Cai et al.
2006). Our results suggest that necrotic cell death was not prevented by SB202190, an
inhibitor of P38. Thus, we would conclude that the P38/MAPK pathway is not
contributing to necrosis in RIN cells treated with CPF.
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Effect of Chlorpyrifos on Insulin Processing and Secretion
Previous data from our laboratory showed that cutaneous CPF exposure led to
insulin reduction in the circulation and decreased insulin content in rat pancreas
(Rutherford and Cool, unpublished data). This specific aim is to investigate whether
insulin secretion is impaired at lower concentrations than lethal doses and its potential
mechanism(s).
This is the first study demonstrating the effects of CPF on insulin secretion in
pancreatic β-cells. Two secretagogues, potassium and glucose were used to evaluate
insulin secretion. The metabolic signaling pathways of glucose and potassium leading
to insulin secretion are different (Figure 30). Glucose has been the most intensively
studied secretagogue. The rise in plasma glucose levels results in an increased flux of
glucose into pancreatic β-cells through the glucose transporter 2 (GLUT2) (Thorens
1992). The cytosolic glucose is then metabolized to glucose-6-phosphate by
glucokinase, the rate-limiting step in glycolysis (De Vos et al. 1995; Newgard et al.
1995). The result of glycolysis is the production of ATP to increase the cytosolic
ATP/ADP ratio (Reimann et al. 2000). In the pancreatic β cells, an increased ATP/ADP
ratio will close the ATP-sensitive K+ (KATP) channels and result in depolarization that in
turn opens voltage-dependent Ca2+ channels (VDCCs) resulting in Ca2+ influx. Insulin
secretion is directly triggered by this Ca2+ influx.
The KATP channel is a heterooctamer composed of 4 units, Kir6.2 with 4
sulfonylurea receptors (SUR1) (Miki et al. 1999). Sulfonylurea drugs for diabetes are
agonist (ligands) of SUR and can thereby close the KATP channels independent of
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metabolic activity. The mitochondria are crucial for the coupling of glucose metabolism
to insulin secretion. Mutations in the mitochondria genome can cause diabetes and poor
release of insulin in response to glucose (Soejima et al. 1996). Cellular models with
DNA-deficient mitochondria are mitochondrial defective and glucose unresponsive as
well. However, the cell retains depolarization-mediated insulin secretion, i.e.,
potassium and sulfonylurea stimulated insulin secretion (Soejima et al. 1996; Kennedy
et al. 1998; Tsuruzoe et al. 1998). Therefore, glucose and potassium usually are used in
insulin secretion analyses to evaluate mitochondrial function. If glucose-stimulated
insulin secretion is abnormal and potassium-stimulated insulin is not affected, the
mitochondria are usually the target. Our results showed that both potassium- and
glucose- stimulated insulin secretion were affected by CPF. This suggests that CPF acts
upstream of glucose metabolism i.e. impaired insulin synthesis, proinsulin processing
and downstream of calcium influx, i.e. exocytosis process.
Our results showed that CPF did not impact basal insulin secretion. RIN cells
stimulated by 50 mM potassium and 25 mM glucose showed significant stimulation in
insulin secretion compared to basal. Our results support that insulin secretion in RIN
cells is through regulated secretory pathway (Bhathena et al. 1984; Santangelo et al.
2007; Mao et al. 2009). However, in the presence of CPF, RIN cells exhibited a
significant reduction in insulin secretion compared to control. This could be explained
by changes in the processing pathway, or by changes in the membrane dynamics that
may prevent fusion of the secretory granules with the membranes or with a weakened
depolarization of the membrane and leakiness that would cause loss of calcium or other
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FIG.30.. Scheme of steps involved in potassium
potassium- and glucose- stimulated insulin
secretion.
1. Glucose transport into
in o cells through glucose transporter 2 (GLUT2)
2. Glucose metabolism in mitochondria to produce ATP
3. ATP sensitive potassium channel closes
close
4.

Open of voltage--dependent Ca2+ channels (VDCCs)
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required ions necessary for secretion.
Proinsulin, however, produced by RIN cells at basal level was higher than
stimulated status (in the presence of 50 mM potassium and 25 mM glucose). While
many studies have shown that proinsulin processing in healthy individuals is in
regulated secretory granules (Halban 1991; Halban 1994), analysis in mouse β TC3
insulinoma cells concluded that newly synthesized proinsulin was released
predominantly via a constitutive, rather than a regulated pathway (Nagamatsu et al.
1992). In addition, studies in mouse pituitary AtT-20 cells also supported that in the
process of prohormone proopiomelanocortin (POMC), a large fraction of
incompletely processed POMC was secreted from immature secretory granules
instead of mature granules in a constitutive-like pattern (Dumermuth et al. 1998).
Based on our results and other studies, we propose that in RIN cells, proinsulin and
their intermediates are sorted out of the immature granules to constitutive-like
vesicles and secreted constitutively (Figure 31B).
CPF concentrations used in our studies were 5-200 µM. Based on pharmacokinetic
models; Buratti et al. proposed that OP concentrations higher than 100 µM reflect acute
accidental intoxication (Buratti et al. 2007). Currently, we do not know how long
CPF-induced decreased insulin secretion will last and whether it is applicable in
humans. Providing CPF induces decreased insulin secretion in humans, the situation
will be worse for those who have diabetes. RIN cells treated with CPF showed a trend
toward decreased intracellular insulin after 4 hr stimulation with 50 mM KCl and 25
mM glucose. Inhibition of insulin biogenesis, i.e. inhibition of proinsulin synthesis is
probably not the explanation as intracellular proinsulin did not change accordingly. In
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(A)

(B)

FIG.31.. Scheme of proinsulin processing in normal β cells via regulated and RIN cells
via constitutive secretory
ory pathway. RER, Rough Endoplamic Reticulum; TGN,
Trans-Golgi Network.
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order to maintain normal insulin secretion and its content in β-cells, the balance
between proinsulin and insulin is very important. Prohormone convertase (PC)
enzymes are responsible for converting proinsulin to insulin. Any deviation of PC
enzymes will cause compromised insulin secretion. The deviation includes the changes
in PC enzyme expressions and their activities. Our results indicated that active PC1 in
RIN cells treated with CPF was upregulated at 4 hr post-exposure. CPF produced no
change on PC2 expression by western blotting. The PC2 enzyme activity assay for the
first time showed that PC2 was inhibited by CPF. An analysis of the slopes of the
activity assay in which a synthetic substrate was cleaved by PC2 showed that the slopes
of the lines for the chlorpyrifos treated cells decreased with increasing concentrations
of chlorpyrifos. The importance of the decreased slope is that CPF is inhibiting the PC2
enzyme activity. Inhibition of PC2 activity would result in decreased processing of
pro-insulin to insulin. The buildup of pro-insulin in the cell would trigger mechanisms
for removal of the extra pro-insulin from the regulated secretory granules to the
constitutive-like secretory granules/pathway. These results suggest a mechanism for
decreased insulin secretion and cellular content. Further experiments are needed to
ascertain that (i) PC1 enzyme activity is affected by CPF; (ii) PC enzyme activity
inhibition is via CPF phosphorylation at an active serine site.
The other possible candidates that could be responsible for impaired insulin
secretion and decreased intracellular content could be (i) inhibition of proinsulin
conversion to insulin other than inhibited PC2 activity, (ii) interrupted insulin
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exocytotic process and (iii) accelerated insulin degradation (Halban et al. 1980; Rhodes
et al. 1988).
A selective inhibitor peptide (CT peptide) was used that was purported to bind with
high affinity to the PC2 enzyme active site, in the experiments on PC2 enzyme activity.
When the reaction buffer containing all the components of the assay was analyzed
using mass spectrometry, the paired lysine residues at the C-terminus of the CT peptide
were found to be removed. Theoretically this should only happen by cleavage with
carboxypeptidases, as are found in the secretory granules of insulin secreting cells.
However, since other enzymes are present in the lysates used for the assay, other
enzymes may also play a role in removal of the lysine residues. The significance for this
observation is that the paired-basic residues are the consensus signal sequence for
cleavage by PC1 and PC2. Their removal may cause the peptide to be removed from the
active site or it may make it bind tighter. No one has yet described this reaction using
mass spectrometry. Therefore, it is unknown what is happening at the enzyme-substrate
level.
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Conclusions
Poisoning by organophosphate insecticides is a major health concern. In addition
to cholinergic effects, hyperglycemia has been observed in both acute and chronic
exposure to OPs. Different mechanisms have been studied for OP-induced
hyperglycemia. However, little is known regarding the effects on pancreatic β-cells. We
used CPF to study the toxicity on insulin-secreting β-cell line RINm5f. Our results
showed that CPF induces a sharp decline of cell survival at concentration of 50 µM as
early as 2 hr treatment. CPF not only induces apoptosis but also necrosis in RIN cells.
The later mechanistic studies indicated that apoptotic death in RIN cells are through
JNK and p38 pathways. ROS is also involved in CPF-induced apoptosis. However,
CPF-induced necrosis has different pathways. Four hour exposure of RIN cells to CPF
concentrations lower than lethal doses (5, 10 and 25 µM) significantly impaired
potassium and glucose-stimulated insulin secretion. Our results imply that for at least a
transit time, CPF induces a reduction in insulin secretion and cellular insulin which
potentially leads to hyperglycemia and diabetic conditions. Decreased insulin secretion
and insulin content can be explained by inhibition of PC2 enzyme activity with no
change in the enzyme protein. In addition, our data, for the first time showed that
proinsulin secretion in RIN cell is through constitutive pathway instead of regulated
pathway. In conclusion, our observation shows that pancreatic β-cells are specific and
sensitive targets for CPF toxicity. Decreased insulin secretion by CPF can be explained
by reduction in β-cell viability and inhibition of PC enzymes.
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Future Study
Molecular Targets of JNK and p38
Currently, JNK and p38 have been shown to medicate two distinct apoptotic
pathways (Aoki et al. 2002; Davis 2000; Dhanasekaran et al. 2008; Kharbanda et al.
2000; Lei et al. 2003; Lin 2003; Minden et al. 1997; Tsuruta et al. 2004). One is called
a mitochondrial pathway; the other is a nuclear pathway. In the mitochondrial pathway,
activated JNK or p38 interacts with antiapoptotic proteins, such as Bcl-2, and
proapoptotic proteins, such as Bim and Bax to induce cytochrome C release from
mitochondria leading to activation of caspase 3 dependent apoptosis. In the nuclear
pathway, activated JNK or p38 can also translocate to nucleus to phosphorylate c-Jun
and/or p53 to initiate transcription of proapoptotic gene such as Bax to induce apoptosis.
Our data suggest that JNK and/or p38 mediate(s) CPF-induced RIN cell apoptosis.
However, the involvement of downstream molecular targets such as Bcl-2, Bax, c-Jun
and p53 needs further study.
PC1 Activity Detection
According to our hypothesis, both PC1 and PC2 enzyme activities should be
inhibited by CPF. However, PC1 enzyme activity was not able to be detected because of
the lack of a specific PC1 inhibitor. A new method needs to be developed to analyze
PC1 enzyme activity.
Prohormone Convertase Catalytic Domain Serine Phosphorylation by CPF
To test if the inhibition of PC enzyme activity is through phosphorylating the serine
site at their catalytic domains, mass spectrometry is needed to be carried out to detected
88

phosphorylation modification on PC enzyme.
Insulin Secretion Changes in Primary β-cell line and In Vivo Study
Since RIN cells are rat insulinoma cells, studies on primary β-cell line and in vivo
studies are necessary to expand our conclusions. The results from these in vivo studies
would provide the framework for a translational approach to studying the effects of
CPF on humans.
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